Press Release | September 26, 2023
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Read More
Press Release | September 21, 2023
Entrada Therapeutics Announces First Participant Dosed in its Phase 1 Clinical Trial of ENTR-601-44 for the Potential Treatment of Duchenne Muscular Dystrophy
Read More
News | September 20, 2023
ImCheck has been short-listed among the top 10 “Biotech et Medtech” companies for the 2023 edition of Les Trophées des Futures Licornes, which rewards the growth potential of innovative French companies.
Read More
Press Release | September 5, 2023
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb
Read More
